ACTA1 and pulmonary fibrosis: AT1R antagonist treatment attenuates the hyperoxia-induced lung fibrosis and decreases the hyperoxia-induced expression of extracellular signal-regulated protein kinase and α-SMA in hyperoxia-exposed newborn rats [22].